Zusammenfassung
Lymphangiosis carcinomatosa bezeichnet eine diffuse Durchsetzung des pulmonalen Lymphgefäßsystems durch Tumorzellen, am häufigsten ist sie beim Mammakarzinom. Differenzialdiagnostisch ist sie abzugrenzen von u. a. einem „capillary-leak-syndrome“, einer pulmonalen Stauung nach Antracyclin-Therapie, einer radiogenen Pneumonitis, einer durch Immunsuppression bedingten atypischen Pneumonie und einer kardial bedingten Stauung. Trotz der sehr schlechten Spontanprognose ist ein therapeutischer Nihilismus keinesfalls gerechtfertigt. Neben der supportiven Therapie (Diuretika, Steroide, Theophyllin, Heparin, Analgetika) sollte eine tumorspezifische Behandlung nicht vernachlässigt werden, beispielsweise durch 5-FU (i.v., z. B. bei Mamma-, Magenkarzinom), Anthrazykline (nicht vorbehandeltes Mammakarzinom), Taxane und neue Zytostatika (Vinorelbin, Taxotere, Gemcitabin), Immuntherapeutika bzw. -modulatoren (Herceptin, Erlotinib). Im Falle sensibler Tumoren kommt der spezifischen hormonellen Therapie besondere Bedeutung zu.
Abstract
Pulmonary lymphangitis carcinomatosis is a diffuse infiltration of the pulmonary lymph vessel system by tumor cells and is most commonly associated with breast cancer. The main factors for differential diagnosis are capillary leak syndrome, pulmonary hypertension after anthracycline therapy, radiogenic pneumonitis, immunosuppression-linked atypical pneumonia and cardiac-linked hypertension. Despite the poor prognosis a therapeutic nihilism is totally unjustified. In addition to supportive therapy (diuretics, steroids, theophylline, heparin and analgesics) a tumor-specific treatment should not be neglected, for example with 5-FU (iv. for breast and stomach cancer), anthracycline (non-pretreated breast cancer), taxanes and new cytostatic drugs (vinorelbin, Taxotere, gemcitabin), immunotherapeutic agents or immunomodulators (Herceptin, erlotinib). In the case of sensitive tumors, a specific hormonal therapy is also extremely useful.
Literatur
Akesaka K, Nakanishi N, Ueda N et al. (2004) A case of carcinomatous lymphangitis of the lungs due to stomach cancer responding to TS-1. Gan To Kagaku Ryoho 31: 233–235
Akiyama Y, Kondo H, Shirono R, Fujii Y (1997) A case of lung adenocarcinoma associated with remarkably high levels of CA 19–9 and lymphangitis carcinomatosa. Gan To Kagaku Ryoho 24: 93–96
Baur M, Schlappack O, Jakesz R, Dittrich C (1992) Unterschiedliche Prognose von Patientinnen mit Mammakarzinom mit Pleuritis carcinomatosa und mit pulmonaler Lymphangiosis carcinomatosa. Wien Klin Wochenschr 104: 714–716
Bruce DM, Heys SD, Eremin O (1996) Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb 41: 7–13
Fabozzi SJ, Schellhammer PF, El-Mahdi AM (1995) Pulmonary metastases from prostate cancer. Cancer 75: 2706–2709
Fujita J, Yamagishi Y, Kubo A et al. (1993) Respiratory failure due to pulmonary lymphangitis carcinomatosis. Chest 103: 967–968
Green N, Kern W, Levis R et al. (1977) Lymphangitic carcinomatosis of the lung: pathologic, diagnostic and therapeutic considerations. Int J Radiat Oncol Biol Phys 2: 149–153
Goldsmith HS, Bailey HD, Callahan EL, Beattie EJ Jr (1967) Pulmonary lymphangitic metastases from breast carcinoma. Arch Surg 94: 483–488
Hamilton CR, Plowman PN (1987) Prolonged remission of lymphangitis carcinomatosis from breast cancer. Br J Dis Chest 81: 400–403
Hojo K, Kumasaka Y, Nishiyama S et al. (1992) A case of adenocarcinoma of lung cancer with multiple brain metastasis and lymphangitis carcinomatosa responding well to chemotherapy with carboplatin, etoposide and ifosfamide. Gan To Kagaku Ryoho 19: 2403–2406
Honda O, Johkoh T, Ichikado K et al. (1999) Comparison of high resolution CT findings of sarcoidosis, lymphoma, and lymphangitic carcinoma: is there any difference of involved interstitium? J Comput Assist Tomogr 23: 374–379
Kokufu I, Tanei T, Taniguchi H et al. (2002) A case of effective paclitaxel therapy for adriamycin resistant metastatic breast cancer with brain metastases. Gan To Kagaku Ryoho 29: 585–588
Levy H, Horak DA, Lewis MI (1988) The value of bronchial washings and bronchoalveolar lavage in the diagnosis of lymphangitic carcinomatosis. Chest 94: 1028–1032
Lower EE, Baughman RP (1992) Pulmonary lymphangitic metastasis from breast cancer. Lymphocytic alveolitis is associated with favorable prognosis. Chest 102: 1113–1117
Mestitz H, Pierce RJ, Holmes PW (1989) Intrathoracic manifestations of disseminated prostatic adenocarcinoma. Respir Med 83: 161–166
Miseria S, Torresi U, Menichetti ET et al. (1991) Lymphangitic carcinomas of the lung as presentation of prostatic cancer. A case report. Tumori 77: 86–89
Mizuiri H, Yoshida K, Shimizu K et al. (2004) Weekly paclitaxel therapy is useful for gastric carcinoma as second-line chemotherapy. Gan To Kagaku Ryoho 31: 2043–2046
Ninomiya J, Horiguchi J, Koibuchi Y et al. (2003) Long-term suppression of lymphangitic lung metastasis from breast cancer using biweekly docetaxel: a case report. Breast Cancer 10: 361–365
Oyama K, Fushida S, Taniguchi K et al. (1999) A case report: modified PMUE therapy might be effective for advanced gastric carcinoma with pulmonary carcinomatous lymphangitis. Gan To Kagaku Ryoho 26: 691–695
Rehbock B, Hieckel HG (2004) Diagnostik der pulmonalen Lymphangiosis carcinomatosa. Radiologe 44: 465–471
Schulze W (1973) Geschwülste der Bronchien, Lunge und Pleura. In: Diethelm L, Olsson O, Strnad F et al. (Hrsg) Handbuch der Medizinischen Radiologie. Bd. 4c. Springer, Berlin Heidelberg New York
Schwarz MI, Waddell LC, Dombeck DH et al. (1969) Prolonged survival in lymphangitic carcinomatosis. Ann Intern Med 71: 779–783
Shure D, Conforti JF (2000) Tissue Procurement: Bronchoscopic Techniques. In: Pass HI, Mitchell JB, Johnson DH et al. (eds) Lung Cancer. Principles and Practice. 2nd edn. Lippincott Williams and Wilkins Philadelphia Baltimore New York London, pp 579–590
Stein MG, Mayo J, Müller N (1987) Pulmonary lymphangitic spread of carcinoma: Appearance on CT scans. Radiology 162: 371–375
Takahashi K, Miyagawa K, Mitachi Y et al. (2003) A case of gastric cancer with metastasis to cervical lymph nodes and pulmonary lymphangitis carcinomatosa responding to neoadjuvant chemotherapy with TS-1 and CDDP. Gan To Kagaku Ryoho 30: 685–689
Watanabe T, Kawabata H, Takase I et al. (2003) A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1. Gan To Kagaku Ryoho 30: 849–853
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kirchner, E., Kirchner, J. & Petrasch, S. Pulmonale Lymphangiosis carcinomatosa. Onkologe 13, 1131–1140 (2007). https://doi.org/10.1007/s00761-007-1285-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-007-1285-x